2024-09-12 | Purchase | Century Therapeutics, Inc. IPSC | director | | $1.53 | $7,657 | -2.6% | |
2023-01-18 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $13.00 | $89,999 | -6.74% | |
2023-01-17 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $12.49 | $62,445 | -1.63% | |
2022-09-01 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $11.29 | $49,621 | +2.9% | |
2022-08-05 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $12.00 | $69,576 | -3.2% | |
2022-06-17 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $9.00 | $39,564 | +22.83% | |
2020-12-21 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $24.09 | $120,474 | -56.42% | |
2020-10-01 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $14.02 | $70,099 | -23.22% | |
2020-07-01 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $15.47 | $212,651 | -6.85% | |
2020-01-09 | Sale | Amicus Therapeutics, Inc. FOLD | Chief Financial Officer | | $9.93 | $297,903 | +44.42% | |
2018-03-09 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Finance | | $10.48 | $183,400 | -11.84% | |
2018-03-01 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Finance | | $9.11 | $148,436 | -6.9% | |
2018-01-02 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Finance | | $12.54 | $200,603 | -6% | |
2017-10-12 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Finance | | $12.23 | $171,210 | +1.4% | |
2016-11-09 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Finance | | $8.00 | $68,368 | -3.86% | |
2015-10-01 | Sale | Amicus Therapeutics, Inc. FOLD | Vice President Finance | | $7.79 | $175,323 | -48.55% | |
2015-09-14 | Sale | Amicus Therapeutics, Inc. FOLD | Vice President Finance | | $18.08 | $90,400 | -60.89% | |
2015-07-01 | Sale | Amicus Therapeutics, Inc. FOLD | Vice President Finance | | $13.98 | $72,700 | -43.01% | |
2015-05-11 | Sale | Amicus Therapeutics, Inc. FOLD | VP Finance and Controller | | $10.84 | $162,612 | -10.41% | |
2014-11-25 | Sale | Amicus Therapeutics, Inc. FOLD | VP Finance and Controller | | $6.08 | $42,560 | +35.35% | |